These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36649363)

  • 1. Correlation study of FGF23/D-serine in maintenance hemodialysis patients with combined hearing impairment.
    Yuan D; Li J; Guo M; Yang Q; Huang J; Nie J; Li R; Li Q
    PLoS One; 2023; 18(1):e0280378. PubMed ID: 36649363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment.
    Nie J; Li Q; Guo M; Li J; Yang J; Chang Q; Cai Y
    PeerJ; 2021; 9():e12295. PubMed ID: 34721981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
    Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
    Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Versus Intravenous Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients on Maintenance Hemodialysis-Effect on Fibroblast Growth Factor-23 Metabolism.
    Fukao W; Hasuike Y; Yamakawa T; Toyoda K; Aichi M; Masachika S; Kantou M; Takahishi SI; Iwasaki T; Yahiro M; Nanami M; Nagasawa Y; Kuragano T; Nakanishi T
    J Ren Nutr; 2018 Jul; 28(4):270-277. PubMed ID: 29703633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients.
    Ashikaga E; Honda H; Suzuki H; Hosaka N; Hirai Y; Sanada D; Nakamura M; Nagai H; Matsumoto K; Kato N; Mukai M; Watanabe M; Takahashi K; Shishido K; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):315-22. PubMed ID: 20609185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of FGF23 and hearing in chronic renal failure and their correlation analysis.
    Li J; Nie J; Zhou Z; Guo M; Yang Q; Yuan D; Huang J; Li R; Li Q
    Cytokine; 2024 Feb; 174():156478. PubMed ID: 38134554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 is a predictor of aortic artery calcification in maintenance hemodialysis patients.
    Chen Z; Chen X; Xie J; Ma X; Zhong F; Hou L; Ling H; Li X; Ren H; Chen N
    Ren Fail; 2013; 35(5):660-6. PubMed ID: 23581403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the Relationship Between Blood Pressure and Serum FGF23 Level in Patients Undergoing Hemodialysis in Guilan Province, A Cross Sectional Study.
    Ramezanzade E; Minoo F; Lebadi MK; Jedinia A; Saheli YH; Aghajanzadeh P; Monfared A; Khosravi M
    Iran J Kidney Dis; 2019 Jul; 13(4):262-268. PubMed ID: 31422393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
    Hsu HJ; Wu MS
    Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis.
    Zaritsky J; Rastogi A; Fischmann G; Yan J; Kleinman K; Chow G; Gales B; Salusky IB; Wesseling-Perry K
    Nephrol Dial Transplant; 2014 Feb; 29(2):437-41. PubMed ID: 24009282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort.
    Toro L; Michea L; Parra-Lucares A; Mendez-Valdes G; Villa E; Bravo I; Pumarino C; Ayala P; Sanhueza ME; Torres R; Elgueta L; Chavez S; Rojas V; Alvo M
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on fibroblast growth factor 23 in chronic kidney disease.
    Wolf M
    Kidney Int; 2012 Oct; 82(7):737-47. PubMed ID: 22622492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23).
    van Helden J; Weiskirchen R
    Scand J Clin Lab Invest; 2018; 78(7-8):584-590. PubMed ID: 30380963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
    Isakova T; Xie H; Barchi-Chung A; Vargas G; Sowden N; Houston J; Wahl P; Lundquist A; Epstein M; Smith K; Contreras G; Ortega L; Lenz O; Briones P; Egbert P; Ikizler TA; Jueppner H; Wolf M
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2688-95. PubMed ID: 21903990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing assessment in Egyptian children with chronic renal failure on regular hemodialysis and renal transplantation children.
    Fadel FI; Yamamah GAN; Hasanin RM; Mostafa EA; Abdalgeleel SA; Salah MM; Galal REE; Abdel Mawla MA
    Ther Apher Dial; 2022 Oct; 26(5):960-968. PubMed ID: 34951736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.
    Grigore TV; Zuidscherwoude M; Witasp A; Barany P; Wernerson A; Bruchfeld A; Xu H; Olauson H; Hoenderop J
    Front Endocrinol (Lausanne); 2022; 13():1046392. PubMed ID: 36699036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Intracranial Artery Calcification with Cognitive Impairment in Hemodialysis Patients.
    Cho NJ; Park S; Lee EY; Oh SW; Oh HG; Gil HW
    Med Sci Monit; 2019 Jul; 25():5036-5043. PubMed ID: 31280282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.